Skip to main content

Table 2 Prescribed ASCVD related treatment

From: Cardiovascular Disease among Syrian refugees: a descriptive study of patients in two Médecins Sans Frontières clinics in northern Lebanon

Drug Overall [95% CI] Abdeh clinic [95% CI] DAZ clinic [95% CI]
ACE-I or ARB 75.7 [71.7, 79.3] 80.3 [74.64, 85.1] 71.8 [66.0, 77.0]
Statin 98.2 [96.5, 99.1] 95.6 [93.1, 98.4] 99.6 [97.7, 100]
Antiplatelet 97.3 [95.3, 98.4] 95.3 [91.5, 97.5] 98.9 [96.6, 99.7]
Β-blocker (BB) 79.1 [75.2, 82.5] 73.8 [67.6, 79.2] 83.5 [78.5, 87.6]
Statin, antiplatelet, ACE-I/ARB 73.5 [69.4, 77.3] 76.4 [70.3, 81.6] 71.1 [65.2, 76.3]
Statin, antiplatelet, ACE-I/ARB/BB 83.2 [79.6, 86.3] 79.8 [74.0, 84.7] 86.1 [81.3, 89.8]